Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
Clinical trial NCT00458822 · COMPLETED
Trial details
- NCT number
- NCT00458822
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.